We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Oncology

Oncology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts
Diabetes & EndocrinologyATA guidelinesPapillary Thyroid Carcinoma

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts

By MedXY|Apr 18, 2026

A retrospective study of 670 papillary thyroid carcinoma patients validates the 2025 ATA risk stratification system, demonstrating a shift toward higher-risk classifications. The new ‘low-intermediate-risk’ class emerges as a di

Early FDG-PET Predicts Survival Outcomes in Metastatic Breast Cancer: IMPACT-MBC Trial Reveals Rapid Response Imaging as a Powerful Prognostic Tool
newsFDG-PETprognostic imaging

Early FDG-PET Predicts Survival Outcomes in Metastatic Breast Cancer: IMPACT-MBC Trial Reveals Rapid Response Imaging as a Powerful Prognostic Tool

By MedXY|Apr 18, 2026

The IMPACT-MBC trial demonstrates that performing FDG-PET after just 2 weeks of first-line systemic therapy can accurately identify metastatic breast cancer patients with distinct long-term outcomes, potentially improving treatment decision

AI Models for EGFR Prediction in Lung Cancer Show Ancestry-Based Performance Gaps
newsancestryEGFR mutation

AI Models for EGFR Prediction in Lung Cancer Show Ancestry-Based Performance Gaps

By MedXY|Apr 16, 2026

A cohort study reveals that open-source AI pathology models predicting EGFR mutations in lung adenocarcinoma demonstrate variable performance across ancestral groups, with notably lower accuracy in Asian patients (AUC 0.68) compared to Euro

Nine-Valent HPV Vaccine Cuts Cancer Risk Nearly in Half for Males: Landmark Study Supports Sex-Neutral Immunization
Infectious Diseasescancer preventionHPV vaccine

Nine-Valent HPV Vaccine Cuts Cancer Risk Nearly in Half for Males: Landmark Study Supports Sex-Neutral Immunization

By MedXY|Apr 15, 2026

A large-scale retrospective cohort study demonstrates that 9-valent HPV vaccination in males aged 9-26 years is associated with a 46% reduction in HPV-related cancer risk. The findings support sex-neutral HPV vaccination strategies and high

ICG Fluorescence-Guided Lymphadenectomy Shows Promise in Improving Lymph Node Detection During Esophagectomy for Esophageal Cancer
General Surgeryfluorescence-guided surgeryIndocyanine Green

ICG Fluorescence-Guided Lymphadenectomy Shows Promise in Improving Lymph Node Detection During Esophagectomy for Esophageal Cancer

By MedXY|Apr 14, 2026

A prospective cohort study of 30 patients demonstrates that indocyanine green near-infrared fluorescence imaging during minimally invasive esophagectomy achieves 80% sensitivity and 99.4% negative predictive value for detecting malignant ly

From 19 to 2: How a Simplified DNA Test Could Revolutionize Endometrial Cancer Detection
newsChảy máu tử cung bất thườngEndometrial Cancer

From 19 to 2: How a Simplified DNA Test Could Revolutionize Endometrial Cancer Detection

By MedXY|Apr 14, 2026

Researchers successfully reduced a 19-marker DNA panel to just 2 methylated DNA markers that detect endometrial cancer with 96% sensitivity and 82% specificity using self-collected vaginal fluid, offering a less invasive alternative to endo

Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial
Gastroenterologyablation therapyhepatocellular carcinoma

Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial

By MedXY|Apr 14, 2026

The NIVOLEP phase 2 trial demonstrates that perioperative nivolumab (neoadjuvant and adjuvant) combined with irreversible electroporation achieves 70.6% one-year local recurrence-free survival in BCLC A HCC patients with high recurrence ris

Three Modifiable Factors Predict Emotional Impairment in Thyroid Cancer Patients: What Clinicians Need to Know
Diabetes & EndocrinologyEmotional functioningoncology

Three Modifiable Factors Predict Emotional Impairment in Thyroid Cancer Patients: What Clinicians Need to Know

By MedXY|Apr 13, 2026

A prospective study identifies exhaustion, head and neck discomfort, and body image concerns as independent predictors of poor emotional functioning in differentiated thyroid carcinoma patients. These findings highlight actionable targets f

Long-Term NSCLC Survivors After Pembrolizumab Show High Survival Rates, Rare Immunotherapy Rechallenge
newsimmunotherapyNon-Small Cell Lung Cancer

Long-Term NSCLC Survivors After Pembrolizumab Show High Survival Rates, Rare Immunotherapy Rechallenge

By MedXY|Apr 14, 2026

A nationwide French cohort study reveals that advanced NSCLC patients completing 2 years of pembrolizumab maintain excellent survival outcomes, with most remaining treatment-free and immunotherapy rechallenge being uncommon.

When Targeting Becomes a Double-Edged Sword: How Loss of GPRC5D May Fuel Multiple Myeloma Progression
Hematology-OncologyGPRC5Dimmunotherapy resistance

When Targeting Becomes a Double-Edged Sword: How Loss of GPRC5D May Fuel Multiple Myeloma Progression

By MedXY|Apr 12, 2026

Researchers discovered that loss of GPRC5D, a key immunotherapy target in multiple myeloma, not only confers resistance to targeted therapies but actively promotes cancer cell proliferation and competitive fitness—creating a therapeutic par

Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer
newscancer recurrencectDNA Biomarkers

Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer

By MedXY|Apr 11, 2026

This study identifies clinicopathologic factors linked to pre- and postoperative levels of circulating tumor HPV DNA (ctHPVDNA) in HPV-mediated oropharyngeal cancer patients treated with upfront surgery, offering insights for disease monito

Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes
newsEndometrial Cancermolecular biomarkers

Molecular Complexity of Endometrial Cancer: How Biomarker Patterns Vary Across Tumor Stages, Histology, and Molecular Subtypes

By MedXY|Apr 9, 2026

A real-world study of 671 endometrial cancer patients reveals significant molecular heterogeneity. PTEN, ARID1A, and PIK3CA are the most prevalent biomarkers, while TP53 mutations and ERBB2 amplification cluster in advanced-stage and non-en

Beyond Simple Quantification: How AI and Tumor-Stroma Ratio Are Redefining Prognosis Prediction in Hepatocellular Carcinoma
newsartificial intelligenceComputational Pathology

Beyond Simple Quantification: How AI and Tumor-Stroma Ratio Are Redefining Prognosis Prediction in Hepatocellular Carcinoma

By MedXY|Apr 9, 2026

Researchers have developed an AI-powered framework that uncovers a non-linear relationship between tumor-stroma ratio and mortality in hepatocellular carcinoma, using a novel token-guided multimodal fusion approach to improve prognostic acc

Immunotherapy Shows Consistent Efficacy in Recurrent Gynecologic Cancers Regardless of Prior Radiation Field Location
newscervical cancerEndometrial Cancer

Immunotherapy Shows Consistent Efficacy in Recurrent Gynecologic Cancers Regardless of Prior Radiation Field Location

By MedXY|Apr 6, 2026

This retrospective study challenges the assumption that prior radiation limits immunotherapy effectiveness in recurrent endometrial and cervical cancers, finding no significant difference in response rates or survival outcomes based on recu

The Gut-Liver Axis Unveiled: How Microbiome Signatures Track Disease Progression from Fatty Liver to Cancer
Gastroenterologybiomarkersgut-liver axis

The Gut-Liver Axis Unveiled: How Microbiome Signatures Track Disease Progression from Fatty Liver to Cancer

By MedXY|Apr 5, 2026

A landmark multicohort study of 1,168 individuals reveals that gut microbiome diversity systematically declines across liver disease stages, with specific bacterial markers like Veillonella and functional metabolic shifts predicting disease

Conversion from Minimally Invasive to Open Pancreatectomy Carries Higher Complication Risk, Study Finds
General SurgeryPhẫu thuật gan tụyPhẫu thuật xâm lấn tối thiểu

Conversion from Minimally Invasive to Open Pancreatectomy Carries Higher Complication Risk, Study Finds

By MedXY|Apr 2, 2026

A large retrospective analysis of over 11,000 patients reveals that conversion to open surgery during minimally invasive left-sided pancreatectomy is independently associated with increased postoperative complications. The findings undersco

Stool Biospecimen Collection in Gynecologic Oncology: New Study Demonstrates Feasibility and Identifies Provider Engagement as Key Driver
newsbiospecimen collectionfeasibility study

Stool Biospecimen Collection in Gynecologic Oncology: New Study Demonstrates Feasibility and Identifies Provider Engagement as Key Driver

By MedXY|Apr 2, 2026

A prospective study evaluating at-home stool collection for gut microbiome research in gynecologic oncology demonstrates implementation feasibility with 61% patient enrollment. Provider engagement emerged as the strongest predictor of parti

Novel Fusion Model Combines Hypoxia and Immune Signatures to Predict Survival in HCC Patients Undergoing TACE Therapy
Gastroenterologyfusion modelhepatocellular carcinoma

Novel Fusion Model Combines Hypoxia and Immune Signatures to Predict Survival in HCC Patients Undergoing TACE Therapy

By MedXY|Apr 2, 2026

A groundbreaking multicentre study develops a clinical-radiologic model integrating hypoxia and immune phenotype signatures to accurately predict prognosis in hepatocellular carcinoma patients treated with transarterial chemoembolisation, p

Patient-Derived Medullary Thyroid Cancer Models Capture Tumor Plasticity and Drug Resistance Beyond Genomics
newsmedullary thyroid carcinomapatient-derived models

Patient-Derived Medullary Thyroid Cancer Models Capture Tumor Plasticity and Drug Resistance Beyond Genomics

By MedXY|Apr 1, 2026

Patient-derived medullary thyroid cancer models preserved tumor heterogeneity, microenvironmental stem-like features, and variable tyrosine kinase inhibitor response, supporting more personalized preclinical testing.

Optimizing the Synergy: Sequential vs. Concurrent Radiotherapy and Immunotherapy in Advanced Non-Small Cell Lung Cancer
Clinical UpdatesimmunotherapyNSCLC

Optimizing the Synergy: Sequential vs. Concurrent Radiotherapy and Immunotherapy in Advanced Non-Small Cell Lung Cancer

By MedXY|Apr 2, 2026

This review evaluates the optimal sequencing of radiotherapy and immunotherapy in advanced NSCLC, highlighting real-world evidence from the OCEANUS study favoring sequential over concurrent administration.

Prev
18 / 25
1…1617181920…25
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles